- 2023-05-05 01:04Enfortumab
- 2023-05-05 01:04Panitumumab
- 2023-05-05 01:03Camrelizumab
- 2023-05-05 01:03Nimotuzumab
- 2023-05-05 01:02Sacituzumab
- 2023-05-05 01:02Vedolizumab
- 2023-05-05 01:02Patritumab
- 2023-05-05 01:02Ixekizumab
- 2023-05-05 01:02Rituximab (anti-CD20)
- 2023-05-05 01:02Pembrolizumab (anti-PD-1)
- 2023-05-05 01:02Nivolumab (anti-PD-1)
- 2023-05-05 01:01Ramucirumab
- 2023-05-05 01:01Disitamab vedotin
- 2023-05-05 01:01Abatacept
- 2023-05-05 01:01Obinutuzumab
- 2023-05-05 01:01Daratumumab
- 2023-05-05 01:01Etanercept
- 2023-05-05 01:01Avelumab
- 2023-05-05 01:01Ipilimumab
- 2023-05-05 01:01Durvalumab
